Novel strategies for the treatment of small-cell lung carcinoma. - Wikidata - awgldk - TriplyDB

Novel strategies for the treatment of small-cell lung carcinoma.

Novel strategies for the treatment of small-cell lung carcinoma.

http://www.wikidata.org/entity/Q37892341

about

Genomic profiling of small-cell lung cancer: the era of targeted therapies Pharmacogenomic approach to identify drug sensitivity in small-cell lung cancer Amide coupling reaction for the synthesis of bispyridine-based ligands and their complexation to platinum as dinuclear anticancer agents Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin.Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma.A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.Staurosporine and extracellular matrix proteins mediate the conversion of small cell lung carcinoma cells into a neuron-like phenotype New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice.Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.Targeted therapies for lung cancer: clinical experience and novel agents Erlotinib resistance in lung cancer: current progress and future perspectives.Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptor.Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.Picoplatin pharmacokinetics and chemotherapy of non-small cell lung cancer.Chemotherapy advances in small-cell lung cancer MicroRNAs: a new key in lung cancer.Smoking, inflammation and small cell lung cancer: recent developments.Optimal drugs for second-line treatment of patients with small-cell lung cancer.Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263.Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer.Synergism of cyclin-dependent kinase inhibitors with camptothecin derivatives in small cell lung cancer cell lines.YES-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl.Adenovirus mediated knockdown of bone morphogenetic protein 2 inhibits human lung cancer growth and invasion in vitro and in vivo.Microbial HSP70 peptide epitope 407-426 as adjuvant in tumor-derived autophagosome vaccine therapy of mouse lung cancer.Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells.Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.Circulating tumor cell interactions with macrophages: implications for biology and treatment.Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.Toppling high-grade pulmonary neuroendocrine tumors with a DLL3-targeted trojan horse.Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.Novel approaches for identification of anti-tumor drugs and new bioactive compounds.Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer.Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.Targeting CREB Pathway Suppresses Small Cell Lung Cancer.

P2860

Q26826915-00790262-A659-4759-BA3E-2CB454D0CEEA Q28542859-BAAB1E8F-4F51-4B2F-B27F-A003DBA2B5DE Q30828730-78C582BF-DDA4-46A6-974C-E965D825D77B Q30851553-9D2C9768-E089-420E-8D48-89D197F753D5 Q34134584-3DFA741E-69BD-4029-A82A-7C475D806413 Q34309915-81158CBB-22E1-40F9-86D0-EA11B5751E71 Q34452854-186CB4C5-CD21-448C-9377-C1D789F51EF9 Q34484195-8EB0F95D-B8E2-4F1B-BC32-AFACB59BB2FB Q34491149-F5085FC6-7CF5-4F65-BDF4-5D1F6C1CD1C4 Q35050907-123A18E5-9404-49CA-BFCB-55F484B1E804 Q35105889-62EB9307-639D-4221-9A3F-F197401593DC Q35538433-4C8FEA25-C238-454B-8C2B-9F1AB338A123 Q36035933-5D48DD56-3C9C-4C9C-BAB9-11C5DE099D90 Q36054970-87475CD7-9E4D-41D0-B28D-886618A14940 Q36605522-E0363379-0EC7-451D-BE12-16AB562506E5 Q36618810-B56EEECD-2B8F-418B-AD4F-C98092A01F73 Q37371697-EE2731D1-456F-48C6-8ECE-84EB8DFDD0DE Q37693082-DCF17CD5-EDAE-4556-A720-D1593664AD35 Q38119531-654C9604-7F30-463C-AABD-8D909F01AC62 Q38155856-9B063CD4-040C-43CF-9139-84F26303BBA8 Q38241121-077BA3CC-4834-46F5-B88E-6FE2F9599975 Q38569752-E780B8D4-C97A-4EF2-B2F6-D61850E04E9B Q38734204-CC4B5520-6184-4B8F-8462-765E293D2F7E Q38807526-1FE6A7E4-52C2-4AA6-8E6F-71A2298B8D99 Q38819019-9BE30DE2-7A78-451F-8D7D-5A77967A6AEC Q39022901-DDC3C4E3-5344-46C2-805F-F05DF8FF4D09 Q39214406-E89F7D02-26D6-49A3-9C68-76CF4A461B2F Q39214413-0B817E2E-B1A4-4695-8D97-C3BD79E18C7C Q39357065-1777A978-B0B8-4840-9094-EDB8D9243965 Q39359766-020AD3FD-044C-40EB-B1BD-DED46A21220A Q41077849-9F7B3F38-EBD3-4429-B311-D05CDC913921 Q41466400-D59E9F92-0F84-49A8-9CFB-557FC9CD7E8D Q41604995-D3A57BF5-3F1C-452E-AE99-AB404C0CE711 Q41900139-6AFB6B14-67EA-446D-BE4C-8B81ED6E9CD8 Q42623025-0BC278AE-42E4-42F6-AA70-1F772261EB69 Q48001140-8428E052-B112-49A5-AD95-0EBDD62BD4F2 Q50277022-2D4C18ED-E31B-4B61-9E72-01B4DF5BCC36 Q50896526-0001A23C-51B7-4896-A94D-0F36263C26C8 Q52657032-E2FE5892-C0AC-48FE-950F-44C1E3E177D8 Q52663619-4812947A-37FF-4015-94F3-FE1FB5147DF9

P2860

Novel strategies for the treatment of small-cell lung carcinoma.

http://www.wikidata.org/entity/Q37892341

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel strategies for the treatment of small-cell lung carcinoma.

@en

Novel strategies for the treatment of small-cell lung carcinoma.

@nl

type

label

Novel strategies for the treatment of small-cell lung carcinoma.

@en

Novel strategies for the treatment of small-cell lung carcinoma.

@nl

prefLabel

Novel strategies for the treatment of small-cell lung carcinoma.

@en

Novel strategies for the treatment of small-cell lung carcinoma.

@nl

P1433

Q37892341-9FCC9AB7-B882-4498-BDB1-92EBBEA9AB35

P1476

Q37892341-50D9C626-E705-4A2C-A3E2-1A3005DC3008

P2093

Q37892341-22450FC8-BDCD-4CEA-95E0-ECC5E43FBDF9

Q37892341-8685217A-A39B-4609-B247-EA67E513B402

P2860

Q37892341-08C90DC8-E882-4259-80C7-2E9F23AE14C4

Q37892341-0C271A07-8D0E-4E23-869D-3BFAED678333

Q37892341-0C91D648-DA6D-4935-813F-A405ACF8F43E

Q37892341-0F441F24-1F45-48E1-B0B5-62DCAF8515F2

Q37892341-11042405-805D-4D62-AE7A-5296E132131A

Q37892341-1176DCF3-22E6-4860-9C92-0C7A5FE351D2

Q37892341-12DB7819-BCC5-4305-88D1-EA476AB5EFB5

Q37892341-16E2CC85-6B95-4902-81CC-C7733A361BA3

Q37892341-1E28DE7C-2216-4643-8C48-43D3779211AE

Q37892341-1F5F9851-1FDF-4C39-B088-0D69B42E4D02

P2888

Q37892341-93869561-B262-4E2C-9FB1-741848026ECF

P304

Q37892341-CF1664DB-5D7A-49E9-99EB-ACA5A5BF377A

P31

Q37892341-7151841A-EB42-4B1B-BEB9-4363BA6676D3

P356

Q37892341-ABAE0D0E-BC08-471F-9C3C-64E47A9E6E00

P407

Q37892341-6D523B09-C86B-44C0-B107-2738E83BEED0

P433

Q37892341-7CA1638D-2B43-431D-BBCC-66E19251A141

P478

Q37892341-CAA8C6B5-5C7E-4880-AAA0-76AE1FFF35A0

P577

Q37892341-CDCB7FF0-E5F5-468D-A664-8B13AC0E8E3C

P6179

Q37892341-D27F29C8-A625-4A9D-A9F8-6C9BF4B29384

P698

Q37892341-6693697D-2954-4558-83FB-94BD67D403A5

P356

NRCLINONC.2011.90

P1433

Nature Reviews Clinical Oncology

P1476

Novel strategies for the treatment of small-cell lung carcinoma.

@en

P2093

Bonnie S Glisson

http://www.w3.org/2001/XMLSchema#string

William N William

http://www.w3.org/2001/XMLSchema#string

P2860

Cigarette smoking and cancer risk: modeling total exposure and intensity

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B

A small-cell lung cancer genome with complex signatures of tobacco exposure

The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy

Mutation analysis of the PTEN/MMAC1 gene in lung cancer

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

P2888

nrclinonc.2011.90

P304

611-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2011.90

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032251011

http://www.w3.org/2001/XMLSchema#string

P698

21691321

http://www.w3.org/2001/XMLSchema#string